Ayla Eker Sariboyaci (Ayla Eker Sarıboyacı)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 6

Top Topics

Transforming Growth Factor

Cataract Surgery

Mesenchymal Stem Cells

Top Venues

Medical oncology (Northwood, London, England)

Current molecular medicine

BioFactors (Oxford, England)

Indian journal of pediatrics

This page only lists publications with an associated author ORCID identifier.

Publications

Özge Sürmeli Onay, Merve Tutal, Burcugul Altug-Tasa, Ozge Aydemir, Tuğba Barsan Kaya, Ayla Eker Sariboyaci, Ayse Neslihan Tekin
Evaluation of the Effect of Breast Milk Storage Conditions on the Viability of Cells in Breast Milk: A Pilot Study. Indian journal of pediatrics (2024)
Burcugul Altug-Tasa, Merve Nur Soykan, Sevinc Eyubova, Ayla Eker Sariboyaci, Cezmi Dogan, Onur Ozalp, Eray Atalay
Crosstalk among miR-29, α-SMA, and TGFβ1/β3 in melatonin-induced exosome (Mel-prExo) treated human limbal mesenchymal stem cells (hLMSCs): An insight into scarless healing of the cornea. BioFactors (Oxford, England) (2024)
Onur Uysal, Haya Erybeh, Mediha Canbek, Emilia Qomi Ekenel, Sibel Gunes Bagis, Gülay Büyükköroğlu, Tugba Semerci Sevimli, Fatih Cemrek, Ayla Eker Sariboyaci
Stem Cell-Based or Cell-Free Gene Therapy in Chondrocyte Regeneration: Synovial Fluid-Derived Mesenchymal Stem Cell Exosomes. Current molecular medicine (2023)
Merve Nur Soykan, Burcugul Altug-Tasa, Harun Bas, Hamed Ghorbanpoor, Huseyin Avci, Sertac Eroglu, Sultan Butun Sengel, Ayla Eker Sariboyaci, Sibel Gunes Bagis, Onur Uysal, Eray Atalay
Developing a Novel Platelet-Rich Plasma-Laden Bioadhesive Hydrogel Contact Lens for the Treatment of Ocular Surface Chemical Injuries. Macromolecular bioscience (2023)
Ayla Eker Sariboyaci, Onur Uysal, Merve Nur Soykan, Sibel Gunes Bagis
The potential therapeutic effect of klotho on cell viability in human colorectal adenocarcinoma HT-29 cells. Medical oncology (Northwood, London, England) 39 (12) (2022)
Sibel Gunes Bagis, Merve Nur Soykan, Ayla Eker Sariboyaci, Onur Uysal, Tugba Semerci Sevimli
Enhancement of Apo2L/TRAIL signaling pathway receptors by the activation of Klotho gene with CRISPR/Cas9 in Caco-2 colon cancer cells. Medical oncology (Northwood, London, England) 38 (12) (2021)